U.S., Jan. 29 -- ClinicalTrials.gov registry received information related to the study (NCT06796270) titled 'Hypofractionated Radiotherapy for Nasopharyngeal Carcinoma' on Jan. 14.
Brief Summary: The purpose of this study was to evaluate the efficacy and safety of large fractionation radiotherapy in nasopharyngeal carcinoma patients, and to analyze whether Hypofractionated radiotherapy is not inferior to conventional radiotherapy.
Study Start Date: Feb. 20, 2026
Study Type: INTERVENTIONAL
Condition:
Nasopharyngeal Carcinoma (NPC)
Intervention:
RADIATION: Hypofractionated radiotherapy
The patients with nasopharyngeal carcinoma were given the dose of large segmentation radiotherapy, 2.64Gy/ time, 5 times/week, a total of 25 times, a t...